MY184297A - Water soluble pharmaceutical film with enhanced stability - Google Patents

Water soluble pharmaceutical film with enhanced stability

Info

Publication number
MY184297A
MY184297A MYPI2016701359A MYPI2016701359A MY184297A MY 184297 A MY184297 A MY 184297A MY PI2016701359 A MYPI2016701359 A MY PI2016701359A MY PI2016701359 A MYPI2016701359 A MY PI2016701359A MY 184297 A MY184297 A MY 184297A
Authority
MY
Malaysia
Prior art keywords
film
moisture
curving
sticky
melt
Prior art date
Application number
MYPI2016701359A
Other languages
English (en)
Inventor
Anwar Siraj Daud
Nidhi Prakash Sapkal
Minal Nandkumar Bonde
Original Assignee
Zim Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zim Laboratories Ltd filed Critical Zim Laboratories Ltd
Publication of MY184297A publication Critical patent/MY184297A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
MYPI2016701359A 2013-10-14 2014-10-13 Water soluble pharmaceutical film with enhanced stability MY184297A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IN2014/000652 WO2015083181A2 (en) 2013-10-14 2014-10-13 Water soluble pharmaceutical film with enhanced stability
IN3221MU2013 IN2013MU03221A (https=) 2013-10-14 2014-10-13

Publications (1)

Publication Number Publication Date
MY184297A true MY184297A (en) 2021-03-31

Family

ID=53274239

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2016701359A MY184297A (en) 2013-10-14 2014-10-13 Water soluble pharmaceutical film with enhanced stability

Country Status (8)

Country Link
BR (1) BR112016008356B1 (https=)
CA (1) CA2927334C (https=)
CL (1) CL2016000880A1 (https=)
EA (1) EA038558B1 (https=)
IN (1) IN2013MU03221A (https=)
MY (1) MY184297A (https=)
UA (1) UA123893C2 (https=)
WO (1) WO2015083181A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015107544A2 (en) * 2013-12-17 2015-07-23 Zim Laboratories Limited Pharmaceutical microemulsion immobilized in a thin polymer matrix and methods of making them
EP3600265A1 (en) * 2017-03-30 2020-02-05 Intelgenx Corp. Method of treatment and device for the improved bioavailability of leukotriene receptor antagonists
DE102017127452A1 (de) * 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag Wasserlösliche Polymerklebschichten
FR3082851B1 (fr) * 2018-06-25 2022-09-02 Biomerieux Sa Procede de detection et/ou d'identification d'au moins un microorganisme cible present sur une surface.
CN119015263B (zh) * 2024-08-20 2025-07-11 云南白药集团无锡药业有限公司 一种云南白药口溶膜剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5947987B2 (ja) * 1979-10-08 1984-11-22 富士写真フイルム株式会社 加筆・修正可能なマツトフイルム
US4664859A (en) * 1983-12-02 1987-05-12 Vcf Films Inc. Div. Of Pmc Process for solvent casting a film
US5272191A (en) * 1991-08-21 1993-12-21 Fmc Corporation Cold water soluble films and film forming compositions
US6966960B2 (en) * 2003-05-07 2005-11-22 Hewlett-Packard Development Company, L.P. Fusible water-soluble films for fabricating three-dimensional objects
WO2005084636A2 (en) * 2004-02-27 2005-09-15 Ranbaxy Laboratories Limited A process for the preparation of controlled-release pharmaceutical composition of metoprolol
KR100705210B1 (ko) * 2004-09-23 2007-04-06 주식회사 한독약품 경구투여를 위한 당뇨병 치료용 약제학적 복합제제
US20090162516A1 (en) * 2007-12-21 2009-06-25 Brown Solomon E Edible, water-soluble film

Also Published As

Publication number Publication date
IN2013MU03221A (https=) 2015-07-03
BR112016008356A2 (pt) 2017-08-01
WO2015083181A3 (en) 2015-12-03
BR112016008356B1 (pt) 2022-12-13
EA201690751A1 (ru) 2016-08-31
CA2927334A1 (en) 2015-06-11
WO2015083181A2 (en) 2015-06-11
EA038558B1 (ru) 2021-09-14
CL2016000880A1 (es) 2017-01-27
CA2927334C (en) 2023-08-29
UA123893C2 (uk) 2021-06-23

Similar Documents

Publication Publication Date Title
MY184297A (en) Water soluble pharmaceutical film with enhanced stability
CY1120492T1 (el) Μια μορφοποιηση φαρμακου καθυστερημενης εκλυσης
BR112018073703A2 (pt) emplastro para pele ou ferida, composição farmacêutica e método para a liberação de uma substância ativa
SG10201808743VA (en) Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa
AR063468A1 (es) Composiciones farmaceuticas
MY167777A (en) A pharmaceutical composition comprising electrohydrodynamically obtained fibres, the composition having improved residence time on the application site
IL299897A (en) Devices and methods for administering multiple units of drug
BR112016002205A2 (pt) filmes orodispersíveis
MX356111B (es) Composiciones farmaceuticas disuasorias de abuso, de liberacion inmediata.
EP2998296A4 (en) CYCLOALKYLIC ACID DERIVATIVE, METHOD OF MANUFACTURING THEREOF AND PHARMACEUTICAL USE THEREOF
WO2015107544A3 (en) Pharmaceutical microemulsion immobilized in a thin polymer matrix and methods of making them
WO2013013038A3 (en) Doping agents and polymeric compositions thereof for controlled drug delivery
MX382580B (es) Formulaciones de liberación inmediata disuasivas de abuso que comprenden polisacáridos no celulósicos.
WO2016140933A3 (en) Immediate release soluble ibuprofen compositions
HK1216839A1 (zh) 调整释放制剂
EA201390979A1 (ru) Композиции бензимидазолов с модифицированным высвобождением
PH12016500693B1 (en) Slow-release solid oral compositions
BR112015010243A2 (pt) dispersão sólida, composição para administração oral, composição farmacêutica, e, método para preparar uma dispersão sólida
EA201001245A1 (ru) Содержащая эстрадиол система доставки лекарственного средства
GB2509460A (en) Coating Composition
HUE069400T2 (hu) Folyékony polimer készítmények és rendszerek peptidek mint hatóanyagok nyújtott leadására
FI20135755A7 (fi) Menetelmä vesiliukoisen kalvon valmistamiseksi ja kalvon käytöt
EA201800197A1 (ru) Способ получения фармацевтической композиции в форме таблеток, содержащих в качестве действующего вещества абиратерона ацетат, и фармацевтическая композиция
Papola et al. Preparation and comparative characterization of drug release from two different chronotherapeutic drug delivery systems of salbutomol for nocturnal asthma.
PH12018550075A1 (en) An oral osmotic pharmaceutical composition of vildagliptin